Viviendas en Arturo Soria

2000/01/01 by Rabia Saleem, Zora R. Rogers, Cindy Neunert +3
Environmental Science · Immunology and Microbiology · Medicine · Social Sciences · #Coagulation, Bradykinin, Polyphosphates, and Angioedema #Complement system in diseases #Latin American Urban Studies #Mexican Socioeconomic and Environmental Dynamics #Renal Diseases and Glomerulopathies #Urbanism, Landscape, and Tourism Studies

paper · doi:10.1111/trf.15093

openalex publication_date 2000/01/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/06/11

Abstract

Maintenance rituximab treatment may be effective for prevention of relapses in patients with acquired, autoimmune TTP, even when splenectomy and intensive immunosuppression, including multiple conventional courses of rituximab, fail to prevent subsequent relapses.

Related

• A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab
• Predictive factors of relapse in pediatric idiopathic thrombocytopenic purpura
• Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies
• Systematic literature review of treatments used for adult immune thrombocytopenia in the second‐line setting
• Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group